FDA Clears the revolutionary Accure Laser for the Treatment of Mild to Severe Inflammatory Acne Vulgaris. 

The Accure laser, developed in cooperation with Quanta System SpA's team, lead by Marco Tagliaferri (PhD, head of El.En.’s medical R&D), Prof. Rox Anderson M.D. and Accure Team, is the first 1726nm-based laser platform with both FDA and CE Mark clearance.